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Abstract
A number of naturally occurring mutations of human apolipoprotein A-I (apoA-I) have been
associated with hereditary amyloidoses. The molecular mechanisms involved in amyloid-
associated pathology remain largely unknown. Here we examined the effects of the Arg173-
Pro point mutation in apoA-I on the structure, stability, and aggregation propensity, as well
as on the ability to bind to putative ligands. Our results indicate that the mutation induces a
drastic loss of stability, and a lower efficiency to bind to phospholipid vesicles at physiologi-
cal pH, which could determine the observed higher tendency to aggregate as pro-amyloido-
genic complexes. Incubation under acidic conditions does not seem to induce significant
desestabilization or aggregation tendency, neither does it contribute to the binding of the
mutant to sodium dodecyl sulfate. While the binding to this detergent is higher for the mutant
as compared to wt apoA-I, the interaction of the Arg173Pro variant with heparin depends on
pH, being lower at pH 5.0 and higher than wt under physiological pH conditions. We suggest
that binding to ligands as heparin or other glycosaminoglycans could be key events tuning
the fine details of the interaction of apoA-I variants with the micro-environment, and proba-
bly eliciting the toxicity of these variants in hereditary amyloidoses.
Introduction
Amyloidoses are a large group of heterogeneous diseases characterized by insoluble proteins in-
ducing organ damage [1]. Many precursor proteins are associated with these pathologies, and
numerous studies have shown that the ability to form amyloid fibrils is an inherent property of
the polypeptide chain sequence. In this respect, different hereditary amyloidoses are due to single
point mutations which increase the pathological behavior of the affected protein. Nevertheless,
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the reason by which the pathway to pathogenicity occurs seems to depend on a large number of
factors either intrinsic to the protein sequence-conformation or to the local micro-environment
in which proteins exert their function. Moreover, a large body of research indicates that, in addi-
tion to the fibers that are the signature of this disease, more disorganized and soluble species
could modulate the cytotoxicity of the misfolded protein conformations [2,3].
Human apolipoprotein A-I is the major protein among high density lipoproteins (HDL), as-
sociated with key functions preventing atherosclerosis. Extensive research supports that the
cardioprotection attributed to the protein is due to its active role in the reverse cholesterol
transport pathway and in the protection against endothelial dysfunction [4–6]. In order to ful-
fill those functions, it was speculated that the in vivo efficiency of apoA-I strongly depends on
its ability to dissociate from spherical HDL giving rise to stable, lipid-poor apoA-I, which can
be rapidly lipidated as a consequence of its interaction with cellular macrophages ATP binding
cassette A1 (ABCA1) transporter [7]. Nevertheless, the structural disorder of the lipid-free con-
formation represents a potential risk of self-aggregation. About 20 mutations in human apoli-
poprotein A-I (apoA-I) have been found associated with hereditary systemic amyloidoses [8]
and it is probable that there are more sequences that have not yet been described, as genetic
studies of hereditary pathologies are not usually performed in underdeveloped countries. Eriks-
son et al. (2009) have identified two ‘hot spots” in apoA-I sequence in which most of the muta-
tions are described [8]. About 50% of the mutants involve substitution of residues in the region
spanning from amino acid 50 to 93, mainly causing patients to suffer from hepatic or renal am-
yloidoses [9,10]. On the other hand, a large number of mutations point to the stretch between
residues 173 to 178, mainly triggering amyloidoses of the heart, larynx or skin. Nevertheless, in
spite of the location of the mutation, proteolysis between residues 83 and 93 is involved in
apoA-I amyloidosis, resulting that the N-terminus is the predominant form of the protein
found in amyloid fibril deposits in patients`lesions [11].
In a previous report, we have studied two natural variants, a deletion mutant Lys107-0, in-
ducing amyloidoses associated to severe atherosclerosis [9] and Gly26Arg, associated with
polyneuropathy [12]. We have identified common and specific events that could mediate the
misfolding of mutants and pathology [13]. Taking advantage of the lessons learned, we moved
forward to understand the consequences of the Arg173Pro mutation, in patients with cardiopa-
thy and skin compromise [14]. We have assayed structural parameters of the target protein
and postulate that the interaction with natural ligands could play-at least in part- an important
role in the pathological pathway caused by this mutant.
Materials and Methods
Guanidine hydrochloride (GndHCl), sodium dodecyl sulfate (SDS) and thioflavin T (ThT)
were from Sigma-Aldrich (St Louis, MO); 1,2-dimyristoylsn-glycero-3-phosphatidylcholine
(DMPC) was from Avanti Polar Lipids (Alabaster, AL). His-purifying resin was from Novagen
(Darmstadt, Germany). Heparin (for clinical application) from bovine intestinal mucosa (aver-
age molecular weight 15 kDa) was from Rivero (BA, Argentina). 4,4’-dianilino-1,1’-binaphthyl-
5,5’-disulfonic acid, dipotassium salt (bis-ANS) was purchased fromMolecular Probes (Invitro-
gen, Carlsbad, CA). All other reagents were of the highest analytical grade available.
Cloning, expression and purification of wild-type (wt) and Arg173Pro
mutant apoA-I
The cDNA for human apoA-I, kindly donated by Dr A. Jonas (University of Illinois at Urbana-
Champaign, IL), was further modified to introduce an acid labile Asp—Pro peptide bond be-
tween amino acid residues 2 and 3 of apoA-I, which allowed specific chemical cleavage of an
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N-terminal His-Tag fusion peptide [15,16]. This construct, inserted into a pET-30 plasmid
(Novagen, Madison, WI), was used to express wt apoA-I, and we have previously checked that
the protein behaved indistinguishably from plasma apoA-I isolated from healthy donors [16].
Next, it was used as a template for the construction of the Arg173Pro mutant. The mutation
was introduced using the Quickchange method (Stratagene, La Jolla, CA). The sequence for the
coding strand of the mismatch primer was the following: 5`- GAGCTGCGCCAGCCCTTGG
CCGCGCG-3`; Protein expression and purification were performed as previously described
[13,15].
Protein denaturation and stability
ApoA-I wt and Arg173Pro were diluted in citrates phosphates McIlvaine`s buffer [17], either
at pH 7.4 or 5.0. Intrinsic fluorescence emission spectra (corresponding to the average signal
from four naturally occurring Trp residues: position numbers 8, 50, 72 and 108 in the primary
sequence of the native protein) were measured at 25°C in an Olis upgraded SLM4800 spectro-
fluorometer (ISS Inc, Champaign, IL), with excitation set at 295 nm, as described elsewhere
[15]. Chemical denaturation was performed by incubation of 0.1 mg/mL apoA-I variants in
the presence of increasing concentrations of GndHCl. In order to correlate the characteriza-
tion of this mutant with other pro-amyloidogenic variants and the wt protein described be-
fore [13,15], the free energy of unfolding in the absence of denaturant (ΔG°) was calculated
from the shift in the spectral center of mass of the fluorescence emission, assuming a two-
state process, as previously described [18,19]. As we are aware that this parameter and also
the maximum wavelength of fluorescence emission [20] hold a non-linear relationship with
the molar fraction of native-or unfolded- protein, the evolution of the emission intensity at
335 nm as a function of GndHCl concentration was also analyzed (not shown). Results de-
rived from this analysis are in good agreement with those presented in this paper. Alternative-
ly, denaturation was monitored by incubating 0.1 mg/mL apoA-I variants with the
fluorescence probe bis-ANS at a 1:1 (probe:protein) molar ratio and measuring emission
spectra after stepwise addition of GndHCl.
Protein structure under native conditions
Solvent exposure of Trp residues was determined by fluorescence quenching induced upon in-
creasing concentrations of acrylamide, as previously described [21] [15]. Proteins were diluted
to a final concentration of 0.1 mg/mL, and quenching measured after stepwise addition of ac-
rylamide. The recovered parameter K is the quenching constant.
The presence of exposed hydrophobic domains in the native structure of apoA-I variants
was assessed by titration with bis-ANS [22,23]. Small aliquots of bis-ANS (from a concentrat-
ed stock solution in methanol) were added to 0.1 mg/mL apoA-I variants at 25°C and fluores-
cence emission spectra acquired between 450–550 nm with excitation set at 395 nm. Residual
methanol concentration was kept to a minimum in order to avoid structural artifacts due to
solvent effects.
Circular dichroism (CD) spectra were registered on 0.1 mg/mL solutions of proteins keep-
ing McIlvaine`s buffer to a minimum to avoid the interference of high salt concentration and
excessive optical background. Spectra were recorded on a Jasco J-810 spectropolarimeter. Data
in the far UV (200–250 nm) region was collected using a 1 mm path-length cuvette. A scan
speed of 20 nmmin-1 with a time constant of 1 s was used for both wt and Arg173Pro mutant
proteins. Each spectrum was measured at least three times and data were averaged to minimize
noise. Molar ellipticity was calculated as described elsewhere [24], using a mean residue weight
value of 115.5 and 115.2 for wt and Arg173Pro proteins, respectively.
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Fluorescence Resonance Energy Transfer of Trp to bis-ANS
Fluorescence resonance energy transfer (FRET) is a distance-dependent interaction between
the electronic excited states of two fluorescent molecules, in which excitation is transferred
from a donor (D) to an acceptor molecule (A), without emission of a photon. The efficiency of
energy transfer (E) can be estimated by the equation:
E ¼ Ro
6
ðRo6 þ Rd6Þ ð1Þ
where Ro represents the Förster radius, the distance where the transfer is 50% efﬁcient (for this
donor-acceptor pair a distance of 26,3 Å is calculated [25]), and Rd is the actual distance be-
tween donor and acceptor. When the donor and acceptor are chemically different, FRET is typ-
ically measured using the relative ﬂuorescence intensity of the donor in the presence (FDA) and
in the absence (FD) of the acceptor [21]:
E ¼ 1 FDA
FD
ð2Þ
In order to determine ﬂuorescence energy transfer, from Trp (donor) to bis-ANS (acceptor),
0.1 mg/mL of the Arg173Pro protein was incubated either at pH 7.4 or 5.0 and the Trp emis-
sion intensity registered, with excitation set at 295 nm and the emission recorded between 300
and 550 nm. Next, the same spectrum was measured after the addition of 1.6 μM bis-ANS. Di-
rect excitation of bis-ANS was achieved at 395 nm.
Detection of protein aggregates
ApoA-I (0.2 mg/mL) variants were incubated at different pH values. After 48 h at 37°C, thiofla-
vin T (ThT) was added at a 1:1 molar ratio and fluorescence intensity was measured on a Beck-
man Coulter DTX 880 Microplate Reader (Beckman, CA), using excitation and emission filters
centered at 430 nm and 480 nm, respectively. When indicated, light scattering was also detected
with the spectrofluorometer, setting both excitation and emission wavelengths at 350 nm.
DMPC clearance assay
Multilamellar liposomes (MLV) were prepared from a stock solution of DMPC in chloroform.
Lipids were dried under N2 atmosphere and resuspended in Tris 20 mM buffer pH 7.4 by ex-
haustive vortexing at 37°C [16]. Proteins, at a final concentration of 7 μM in the same buffer
were incubated at 24°C with DMPCMLV, at a molar ratio lipid:protein 40:1 and absorbance
monitored by 90 min using a 350 nm filter on the Microplate Reader. The final products after 1
and 2 h incubation were analyzed by polyacrylamide gradient gel electrophoresis under non-
denaturing conditions (PAGGE).
Binding of ligands to apoA-I variants
Wt and Arg173Pro (0.2 mg/mL) proteins were incubated with 0.2 mM SDS (either at pH 7.4 or
5.0) for 48 h at 37°C. Complex formation was detected by the binding to ThT as described
above. Protein binding of heparin was tested following incubation of 0.2 mg/mL proteins with
heparin at a 2:1 heparin/protein molar ratio for 48 h at 37°C. In order to confirm whether bind-
ing to heparin results in the formation of high molecular weight complexes, the incubation
mixtures were analyzed by PAGGE. In a separate experiment, the Arg173Pro variant was incu-
bated at 0.5 mg/mL and pH 7.4 for 24 h at 37°C in the absence or in the presence of heparin,
and morphology was compared by atomic force microscopy (AFM) as described previously
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[13]. All images were obtained at room temperature using a Multimode-Nanoscope V (Veeco,
Santa Barbara, CA) operating in tapping mode with an etched silicon Probe model Arrow-
NCR-50 NanoWorld (cantilever resonance frequency: 258 kHz, Force constant 42 N/m; tip ra-
dius 5–10 nm). Typical scan rates were 1–1.5 Hz.
Other analytical methods
In order to ensure freshly, natively folded states, proteins were dissolved in ~2 M GndHCl and
extensively dialyzed right before each experiment. Protein content was quantified by the Brad-
ford technique [26], or by measuring optical density in a Bio-Rad spectrophotometer (Hercu-
les, CA), using an extinction coefficient of 32,430 M-1cm-1 at 280 nm. Unless otherwise stated,
results are representative of three independent experiments. Results are means ± standard
error of at least three samples.
Results
Stability and conformation as a function of pH
In order to characterize the effect of the substitution of an Arg residue by a Pro in the protein
structure and stability, we set out to analyze whether this variant exhibited structural differ-
ences in the native state as compared with the wt protein. The far-UV circular dichroism (CD)
spectra reveals a ~ 35% reduction in the secondary structure content of Arg173Pro with respect
to the wt form (Fig 1A). A small but significant change in Trp environment was estimated by
the analysis of the quenching effect with acrylamide. A significantly higher Stern-Volmer con-
stant (K) measured for this mutant indicates an enhanced exposure of Trp residues to the sol-
vent, as compared to the wt form (Table 1). In order to get further insight into the tertiary
structure, proteins were titrated with bis-ANS, a dye which has been shown to be sensitive to
hydrophobic surfaces and flexible structures [18]. The high fluorescence quantum yield associ-
ated to the binding of this probe supports previous notions of a spatial organization of the wt
protein as a molten globule-like structure in the native state [15,18,19,23]. In addition, the
Arg173Pro variant exhibits a higher quantum yield of the bound probe (Fig 1B), suggesting
some difference in the spatial arrangement of the proteins. Together, these results suggest that
the substitution of an Arg by a Pro induces conformational changes of the N terminal domain
of apoA-I (where the Trp residues are located) that results in higher exposure of the Trp resi-
dues and of a hydrophobic protein surface to the aqueous medium.
Protein structure stability was investigated by equilibrium unfolding experiments, by fol-
lowing the intrinsic fluorescence emission at increasing concentrations of GndHCl. As it is
well-known, chemical denaturation of wt apoA-I is described at pH 7.4 by a two-state denatur-
ation model (Fig 2), from which the free energy of unfolding can be estimated [27]. In agree-
ment with previously reported data, the measured ΔG° is 2.5 ± 0.3 kcal/mol, typical of a
partially folded protein. Interestingly, the Arg173Pro denaturation behavior could not be fit to
the two-state-model, thus preventing the estimation of ΔG°. Instead, even at the lowest
GndHCl concentration assayed (0.1 M) a shift toward longer wavelengths is observed, indicat-
ing an enhanced exposure of Trp residues, giving hints on decreased stability. The apparent
GndHCl concentration at which half of the protein is unfolded [GndHCl]1/2, is also significant-
ly lower for this mutant (0.5 M) than for the wt variant (0.9 M (Table 1)).
Binding lipid properties of the lipid-free variants
In order to detect whether Arg173Pro keeps its functional role in lipid solubilization, we incu-
bated this protein with DMPC vesicles at the lipid transition temperature (24°C) and compared
Amyloidogenic Propensity of the Apolipoprotein A-I Arg173Pro Mutant
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its ability to form protein: lipid complexes by following the decrease in turbidity at 350 nm. As
Fig 3A shows, lipid clearance was less efficient for Arg173Pro. In addition, the products after 1
or 2 h incubation were characterized by PAGGE (Fig 3B). As previously observed wt readily
yielded a homogeneous population of around 230 kDa, indicating high efficiency to rearrange
and to solubilize lipids. Instead the most of the Arg173Pro remained as lipid-free or lipid—
poor protein and some amount recombined in higher size particles. This pattern was man-
tained after 24 h (results not shown).
Fig 1. Spectroscopical characterization of protein structure.Wt and Arg173Pro variants (0.1 mg/mL)
were dissolved in citrates phosphates McIlvaine’s buffer, pH 7.4. A) Far-UV circular dichroism. Dark and light
grey lines correspond to wt and Arg173Pro proteins, respectively. B) Proteins were incubated with increasing
concentrations of bis-ANS. The probe was excited at 360 nm, and the emission recorded at the wavelength of
maximum fluorescence for this probe (488 nm). Filled and open circles represent the experimental data
points for wt and Arg173Pro, respectively.
doi:10.1371/journal.pone.0124946.g001
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Formation of amyloid-like aggregates
Then we analyzed the relative tendency of the Arg173Pro variant to aggregate even at physio-
logical pH. The fluorescence quantum yield of ThT is very low in aqueous buffer and markedly
increases upon binding to protein amyloids [28,29]. In agreement with previous data, even
after 48 h incubation at pH 7.4, the wt form shows very low ThT associated fluorescence. In-
stead, fluorescence is significantly enhanced when ThT is bound to the Arg173Pro variant
Table 1. Fluorescence characterization of wt and Arg173Pro forms at pH 7.4 and 5.0.
Protein variants K (M-1)a ΔG° denat b (kcal/mol) [GndHCl]1/2
c Scattering d Ee bis-ANS /Trpf
pH 7.4
wt 5.58 ± 0.42 2.5 ± 0.3 0.9 M ± 0.2 1.05 ±0.32
Arg173Pro 7.81 ± 0.91 N/A 0.5 M ± 0.3 2.17±0.38 0.23± 0.03 1.35± 0.41
pH 5.0
wt 5.78 ± 0.87 2.4 ± 0.3 0.9 M ± 0.3 2.20±0.08
Arg173Pro 6.14 ± 0.80 N/A 0.5 M ± 0.2 6.23±2.23 0.38± 0.04 1.40± 0.42
a Stern-Volmer constant for the quenching of Trp residues by acrylamide.
b Free energy change of unfolding and
c concentration at which half of the protein is unfolded, respectively, calculated from equilibrium unfolding curves, as described previously [18] and shown
in Fig 2. N/A, not assayed
d Light scattering of proteins (0.2 mg/mL) measured after 48 h incubation at 37°C with excitation and emission wavelengths set at 350 nm.
e Fluorescence resonance energy transfer efﬁciency (E), calculated from Eq (2). FDA and FD are the intensity of Trp emission in the presence and in the
absence of the acceptor molecule bis-ANS (excitation set at 295 nm and emission at 335 nm).
f Intensity ratio of the ﬂuorescence associated to bis-ANS and Trp in the samples described above, measured by direct excitation of each dye, as
described in ‘Methods’.
doi:10.1371/journal.pone.0124946.t001
Fig 2. Chemical denaturation as followed by GndHCl titration. Proteins (0.1 mg/mL in citrates
phosphates Mc Ilvaine’s buffer, pH 7.4) were incubated with increasing concentrations of GndHCl. Trp
fluorescence emission spectra were obtained by excitation at 295 nm, and scanning the emission between
310 and 420 nm. With these data, the center of mass was calculated for each sample. Filled and open circles
represent the experimental data for the wt and Arg173Pro variants, respectively.
doi:10.1371/journal.pone.0124946.g002
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(Fig 4A). This evidence agrees with the formation of pro amyloidogenic protein complexes,
which should be of larger size than wt, as suggested by higher light scattering values (Table 1).
This tendency was demonstrated to be dependent on protein concentration and incubation
time (results not shown). The characterization of protein aggregates by atomic force microsco-
py (AFM) indicates the main presence of aggregates of heterogeneous size (Fig 4B), and even
the presence of some elongated structures detected at higher magnification (inset). In order to
estimate the dimensions of the oligomers, their height was measured and represented in a his-
togram (Fig 4C). A wide, monomodal, slightly skewed distribution is observed, with most of
the aggregates showing a height between 22 and 25 nm. This pattern is significantly different
from that observed for the wt form assayed under the same conditions, in which a homoge-
neous, smaller size oligomer distribution is the characteristic feature [13]. Upon aggregation of
the Arg173Pro variant, a decrease in the far UV-CD intensity is observed (especially at pH 5.0).
Nevertheless, no conclusive information about the nature of the aggregates can be obtained
due to the high proportion of native protein remaining soluble (result not shown).
Effect of pH on protein structure, stability and aggregation propensity
Our previous results indicate that a mild decrease in the local pH does not induce drastic changes
on the wt protein structure under short time incubation at room temperature [15]. As a change
in net charge is expected for the mutant protein (a positively charged Arg residue is replaced by a
neutral Pro) we set out to analyze the influence of acidic pH on the conformation of this variant.
The CD spectrum (Fig 5A) and the chemical denaturation profile (Fig 5B) of the Arg173Pro mu-
tant are preserved and look almost indistinguishable from those observed at pH 7.4.
To get further information on the effect of pH on protein folding, we analyzed the efficiency
of energy transfer from Trp to the acceptor dye bis-ANS. Efficient energy transfer is detected
either by the decrease in the emission intensity of the Trp residues, or by the increase in bis-
ANS fluorescence (Fig 5C). In order to quantify FRET efficiency Eq (2), we registered Trp fluo-
rescence emission before (filled line) and after the addition of bis-ANS (dotted line). As shown
in Table 1, the efficiency of energy transfer is 0.38 at pH 5.0, a value about 15% higher than
that measured at pH 7.4 (0.23). Under this acidic condition, there is a small, albeit not signifi-
cant, increase in the ratio of bis-ANS (by direct excitation) vs. Trp fluorescence emission
Fig 3. Characterization of spontaneous formation of lipid:protein complexes. A) Multilamellar DMPC
liposomes were incubated at 24°C and Absorbance measured at 340 nm without (black) or with wt (dashed)
or Arg173Pro (grey line) proteins at a 40:1 lipid to protein molar ratios. B) Native 4–24% PAGGE analysis of
the final product after incubation of wt (lanes 2 and 4) or Arg173Pro (lanes 3 and 5) with DMPC at 24°C for 1
or 2 h, respectively. Lane 1 corresponds to High molecular weight standards 669, 440, 232, 140 and 67 kDa
(Amersham Biosciences, UK).
doi:10.1371/journal.pone.0124946.g003
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(Table 1). The intensity measured was registered after stepwise addition of GndHCl. As it was
observed before [13], bis-ANS fluorescence decreases sharply following a monotonous trend
with increasing GndHCl concentration, a feature indicating the presence of a flexible structure
with hydrophobic patches maximally exposed in the native state. The effect was similar at both
pHs tested. We then proceeded to analyze the propensity of proteins to aggregate at pH 5.0.
After 48 h incubation at 37°C, the Arg173Pro variant exhibits a higher level of ThT emission
intensity than the wt protein (Fig 5D) and scatters more light (Table 1).
Ligand binding
The conversion of soluble, natively folded proteins into misfolded aggregates usually involves
structural transitions leading to the partial or complete disruption of the native structure.
Along this pathway, it has been suggested that weak interactions of the protein with molecules
belonging to the micro-environment could favor the shift of the equilibrium toward a
Fig 4. Characterization of Arg173Pro aggregates at pH 7.4. A) Binding of ThT to apoA-I. Proteins (0.2 mg/
mL in citrates phosphatesMcIlvaine’s buffer, pH 7.4) were incubated for 48 h at 37°C and ThT added to each
sample at a 1:1 molar ratio to protein. Fluorescence was quantified in the microplate reader at 480 nm
(excitation set at 430 nm). Bars correspond to means ± SE. Statistically significant differences between
experimental conditions were evaluated by Student t test. Symbol * denotes a difference with respect to wt at
p<0.05. B) Characterization of the morphology of Arg173Pro aggregates after analysis of AFM images. Protein
(0.5 mg/mL) was incubated for 24 h and loaded onto mica plates. Heterogeneous size oligomers covering the
surface of the mica were predominant in the sample. The inset represents a frame at higher magnification,
allowing us to observe elongated aggregates with a protofibrillar shape. Bars show the scale used in each
case. C) Histogram distribution of the height of the oligomers obtained frommeasurements in the z-plane.
doi:10.1371/journal.pone.0124946.g004
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pathological conformation. SDS mimics some characteristics of biological membranes, and it
has been described as an inducing agent for the formation of fibrils from different peptides and
proteins when used below the critical micellar concentration (CMC: 0.7 mM) [30,31]. Within
this frame, we analyzed the effect of SDS on the aggregation of wt protein and its pathological
mutant, and the effect that the decrease in pH could bring about in promoting this interaction.
Fig 6A shows that incubation of each protein with 0.2 mM SDS (either 5.0 or pH 7.4) elicits
ThT binding, this effect being more pronounced for the Arg173Pro variant. This binding de-
creases in the presence of NaCl (Fig 6B) and is more notorious at pH 5.0 (not shown).
Next we set out to check the effect of heparin as a putative ligand. We have previously shown
that the wt form does not significantly interact with heparin at pH 7.4 [13]. In order to compare
this behavior with that of the mutant, we incubated the Arg173Pro variant with heparin at this
pH and analyzed the possibility of complex formation by native gradient gel electrophoresis
(PAGGE) (Fig 7A). As expected, lanes containing proteins without heparin (lanes 1 and 2)
showed bands migrating about a position consistent with the MW expected for the monomers.
When the wt form was incubated in the presence of heparin, most of the intensity remains asso-
ciated to this band (lane 3), confirming that no significant interaction occurs under this condi-
tion. By contrast, the incubation of the Arg173Pro variant with heparin for 48 h results in the
Fig 5. Protein structure, stability and aggregation tendency at pH 5.0. A) Proteins were dissolved in
citrates phosphates McIlvaine’s buffer, pH 5.0 and far-UV circular dichroism measured as describe above.
Dark and light grey solid lines correspond to the wt and Arg173Pro variants, respectively. To facilitate
comparison, dashed lines correspond to both proteins measured at pH 7.4 (as shown in Fig 1A); B)
Arg173Pro (0.1 mg/ml, pH 5.0) was incubated with increasing concentrations of GndHCl and the center of
mass of the Trp fluorescence measured as described above (filled circles). Here again, to facilitate
comparison, dashed lines correspond to the protein measured at pH 7.4 (as shown in Fig 2). C) Analysis of
energy transfer from Trp to bis-ANS. The Arg173Pro variant was dissolved in citrates phosphates McIlvaine’s
buffer (0.1 mg/mL) and Trp fluorescence measured (with excitation set at 295 nm, continuous line). Bis-ANS
was added next and spectra measured (with excitation set at 295 nm, dotted line). Direct excitation of bis-
ANS was achieved at 395 nm (dashed line). Dashed and dotted line represents bis-ANS excitation at 295 nm
in protein-free buffer. Efficiency was calculated by measuring the intensity of Trp fluorescence at the
wavelength of maximum emission (335 nm). D) Binding of ThT to apoA-I. Proteins (0.2 mg/mL in citrates
phosphates McIlvaine’s buffer, pH 5.0) were incubated for 48 h at 37°C and ThT added to a 1:1 molar ratio to
protein. Fluorescence intensity was quantified in the microplate reader at 480 nm (excitation set at 430 nm).
Bars correspond to means ± SE. Statistically significant differences between experimental conditions were
evaluated by Student t-test. The symbol * denotes a difference with respect to wt at p<0.05.
doi:10.1371/journal.pone.0124946.g005
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disappearance of the monomer band (lane 4), thus indicating the formation of larger com-
plexes. In order to get further insight into this phenomenon, we compared this product under
AFM. In this case, we could detect aggregates that were about 5 nm high, more extended and
more amorphous than those of the protein in the absence of heparin (Fig 7B and 7C).
Fig 6. Protein binding to SDS. A) The wt and Arg173Pro variants (0.2 mg/mL) were incubated (either at pH
7.4 or 5.0) in the absence or in the presence of 0.2 mM SDS. After 48 h at 37°C ThT was added to a 1:1 molar
ratio to protein. Fluorescence intensity was quantified in the microplate reader at 480 nm (excitation set at
430 nm). Statistically significant differences between experimental conditions were evaluated by ANOVA
followed by Tukey’s test. Bars correspond to means ± SE. The symbol * denotes difference with respect to wt
at p<0.01. B) The effect of salt concentration was tested by incubating Arg173Pro (0.2 mg/mL) at pH 7.4 in
the absence or the presence of 0.2 mM SDS plus 0, 100 and 400 mMClNa. Incubation was performed as in
A). The symbol # denotes difference with respect to the protein in the absence of ClNa at p<0.01
doi:10.1371/journal.pone.0124946.g006
Fig 7. Characterization of heparin binding to apo A-I variants. Polyacrylamide gradient gel
electrophoresis (PAGGE, 4–25%) under native conditions. wt (lane 1) and Arg173Pro variants (lane 2); lanes
3 and 4 correspond to wt and Arg173Pro variants plus heparin (added at a 2:1 heparin to protein molar ratio),
after 48 h incubation at 37°C at pH 7.4. B) Characterization of the morphology of Arg173Pro aggregates with
heparin. Analysis of images observed under AFM. Proteins (0.5 mg/mL) were incubated for 24 h and loaded
onto mica plates. The bar shows the scale indicated in the image. C) Distribution of the height of oligomers
resulting from the measurement in the z-plane. D) Proteins (0.2 mg/mL in citrates phosphates McIlvaine’s
buffer, pH 5.0) were incubated for 48 h at 37°C in the presence or in the absence of heparin at a 1:1 molar
ratio. Binding of ThT was measured as described above. Bars correspond to means ± SE. Statistically
significant differences between experimental conditions were evaluated by Student t-test. Bars correspond to
means ± SE. The symbol * denotes the difference with the same protein without heparin at p<0.01.
doi:10.1371/journal.pone.0124946.g007
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Finally, we analyzed the influence of low pH on the efficiency of proteins-GAGs interaction.
Due to the negative charge of GAGs, binding to proteins is expected to be more efficient at
lower pH as the protonation of His residues results in enhancement of the net positive charge.
We have previously confirmed that finding with the wt form [15]. Here, when incubating the
apoA-I variant and the wt form at pH 5.0, even though both proteins show a high level of ThT
binding, the yield in fluorescence was higher for wt than for the Arg173Pro mutant (Fig 7D).
Discussion
The tale of interactions among apoA-I and ligands in circulation is largely studied in order to
understand the main role of this protein in lipid homeostasis. However, little is known about
the influence of the surroundings on protein misfolding and/or malfunction. We have previ-
ously suggested that a pathological landscape associated to inflammation could elicit the pro-
amyloidogenic potential of the wt protein, as it is the case that could occur in the atherosclerot-
ic plaque [9]. Nevertheless, the fact that severe amyloidoses are associated with point mutations
in the protein sequence indicates that substitution or deletion of single amino acids could be
critical to determine a pathway leading to defects in protein folding. Previous reports of our
and other groups indicate that the structural features determining apoA-I amyloidogenicity are
not strictly shared by all the mutants described in patients [13].
With this frame in mind, we characterized here structural consequences that could determine
the pathogenicity of mutant Arg173Pro. As it was discussed above, substitution of an Arg by a
Pro residue occurs in the so-called ‘hot spot’ domain of apoA-I, meaning that the disruption of
this domain must bear a drastic effect on protein function or metabolism. The helix in which
mutation occurs has been involved in lipid binding and lecithin cholesterol acyl transferase activ-
ity [32]. Our lipid-binding assay supports an impaired role of the protein to efficiently solubilize
lipids from a bilayer, which is in agreement with the fact that HDL cholesterol levels of patients
heterozygous for the mutation are low [14]. If this is the case, consequence could be not only a
loss-of-protein function but in addition it could result in relatively higher amount of lipid-free or
lipid-poor protein which is more sensitive to be modified by partners in the micro environment.
Effect of destabilization of the native state on protein aggregation
For many amyloidogenic proteins, destabilization of the native globular state by mutations or
by modification of the environment is highly correlated with the formation of amyloid fibrils,
suggesting that the perturbation of the native folding is the critical event triggering amyloid for-
mation [29,33,34]. Nevertheless, the surprising fact that the most destabilizing TTRmutants,
Asp18Gly and Ala25Thr, are not the most pathogenic [35], indicates that the proposed correla-
tion between stability and pathogenicity might indeed exist, but it should not be taken as a sine
qua non condition. In support of this, it has been recently shown that stability is not a key event
triggering amyloidogenicity of two natural mutants of apoA-I modified in the N-terminus [36].
Along this line of thought, we set out to determine whether a correlation could be found be-
tween the Arg173Pro propensity to misfold and its stability. The natural variant protein shows
under physiological pH significantly lower (and less cooperative) chemical denaturation stabili-
ty than the wt form, together with a partial loss of secondary structure, which might contribute
at least in part to the higher aggregation tendency of the mutant. The red shift in Trp fluores-
cence of the Arg173Pro mutant, even at the lowest guanidinium concentration assayed, and a
higher susceptibility to fluorescence quenching of these residues, indicate that the N-terminus
of apoA-I (which holds in average the four natural Trp), is more solvent exposed in the mutant.
Based on the recently obtained crystal structure of the C-terminal truncated apoA-I [37],
Gursky et al proposed that either in the monomer or the dimer arrangement, lipid-free apoA-I
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structure is stabilized by two symmetry-related four-segment bundles at the opposite ends.
They suggested that natural amyloidogenic mutations (comprising residues 44–120 and 154–
184) occur in key positions in the helical bundle that disrupt this arrangement. The introduc-
tion of a Pro in the place of an Arg in position 173 should induce a kink in the helical sequence
repeat 7 (residues Pro165−Gly185), which is expected to disorganize the interactions of this he-
lical segment with the juxtaposed segment from repeats 2 and 3 [37]. If this is the case, it could
be proposed that Trp 72 (in the helix 2), could be shifted from the native conformation in the
protein structure. Interestingly, the N-terminus’ propensity to form amyloid structures was pre-
viously described [38] but in addition, the Trp 72 is comprised in one of the four hot spots pre-
dicted in apoA-I by applying AMYLPRED2 (peptides 14–22, 53–58, 69–72 and 227–232) [36].
Incubation of this variant under mild low pH does not seem to drastically contribute to protein
stability and folding. Even though small structural changes were observed in the Trp environ-
ment after incubation of Arg173Pro at pH 5.0 (by quenching and FRET) the ThT associated
fluorescence was about ~ 2.5–3 times higher than the intensity observed at pH 7.4, which is sim-
ilar to the ratio measured for the wt under the same conditions.
Lessons learnt from the binding of ligands
It has been previously shown that the lipid microenvironment could induce a conformational
shift of apoA-I or peptides derived from terminal domains [39,40]. The presence of negatively
charged lipids in the plasma membrane is a common hallmark associated to atherosclerosis or
other local chronic inflammatory events inducing apoptosis. If this were the case, proteins
could be exposed to local acidification in the interstitial fluid [41], which in turn could elicit the
conformational shift of apoA-I into a pathologically misfolded state. In order to consider this
hypothesis, we first checked the aggregation tendency of apoA-I variants in the presence of the
negatively charged SDS, confirming an increased tendency to form amyloid-like aggregates ei-
ther at pH 5.0 or 7.4. The headgroup of this amphiphile could participate in electrostatic bind-
ing with positive charges of the protein, which is in agreement with the loss of ThT binding
observed in the presence of high concentrations of ClNa (Fig 6A). Nevertheless Arg173Pro var-
iant was more efficient to give rise to pro-amyloidogenic complexes at both pH conditions as-
sayed in spite of the loss of a positive charge (replacement of an Arg by a Pro). Thus, it is likely
that, as it was suggested for the aggregation of other proteins as synuclein [42] and peptides
[43], that alkyl chains of SDS could stimulate aggregation, perhaps by association with the non
polar phases of the amphipatic helices, forcing intermolecular interactions.
Heparin and other glycosaminoglycans (GAGs) have been shown to interact with a wide va-
riety of molecules, modulating numerous biological processes and to induce fibril or other mis-
folded conformations from many proteins [44]. In this context, we previously shown that wt
apoA-I does not significantly bind heparin under physiological pH, but through a putative site
generated under acidic pH following protonation of His 155 and 162 in the class A α-helix 6
[15]. When analyzing the Arg173Pro mutant, the ThT associated fluorescence was relatively
decreased in the binding to heparin with respect to the wt protein at pH 5.0, a fact that could
be explained by a lower efficiency to bind this GAG (Fig 7D). But especially interesting we be-
lieve it is the fact that, instead, the mutation induces a significant formation of complexes at
pH 7.4 (Fig 7A and 7C). In order to find a possible explanation for this behavior, we built a
model of the sequence of apoA-I involving helix 6 and 7 (Fig 8A). Arg 173 is located approxi-
mately in the middle of the putative helix 7 (comprising residues 165–186) and the helical
wheel model predicts this residue to be facing the hydrophobic side of the amphipatic helix.
Gursky et al proposed [37] that replacement by Pro (in light blue in Fig 8B) places a polar
group in the bottom hydrophobic cluster and disrupts the native conformation around this
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region and -as a consequence- a significant alteration of the subtle interactions with neighbor-
ing helices that help to stabilize the entire molecule. By using the SOPMA secondary structure
predictor software (www.expasy.org) for this region of apoA-I, the introduction of the Pro
should induce a random coil segment of 4 amino acids disrupting the alpha helix. If this point
mutation affects heparin binding, we could suggest that helix 7, in which the mutation occurs
may be implicated in the binding motif involving helix 6 under acidic condition. The loss of
the local positive charge, plus the disrupting effect of the Pro residue, could partially disorga-
nize the spatial arrangement that is created under low pH, thus causing the decrease in ThT
binding observed for the complex (Fig 7D).
On the other hand, the inclusion of the Pro residue results in the formation of a protein-
GAG complex at pH 7.4 (Fig 7A and 7C). We can speculate that the disruption of helix 7 allows
the exposure of cryptic residues that could potentially interact with the GAGs constituting a
second binding motif. These helices contain several positive residues that could participate in
this interaction: 3 Arg residues are aligned in helix 6 [15] and -in addition- helix 7 contains 3
positive residues as well (Arg 171, Arg 177 and Lys 182: Fig 8). All in all, we believe that the
findings presented here offer new clues that help to understand pathological pathways, suggest-
ing specific binding of the mutants to GAGs in a physiological context.
Along this line of evidence, examination of a heart specimen from a patient diagnosed with
amyloid cardiomyopathy revealed substantial heparan sulfate accumulation in TTR amyloid
deposits [45]. It is known that GAGs play complex functions in cell events as diverse as prolif-
eration or aging [46,47]. In addition, it was recently proven that low molecular weight derma-
tan sulfate modulates endothelial cell proliferation and migration [48]. It is worth noting that
scientific evidence supports that GAGs could participate in the amyloidogenesis in vivo, per-
haps even in a protective role, by conversion of proteotoxic soluble oligomers into less toxic
amyloid fibrils and related cross-β-sheet aggregates [49]. In our knowledge, it is not yet known
the structure of apoA-I variants that could be more toxic inducing organ damage. Further re-
search needs to be carried out in order to get a deeper insight into the cross-talk of apoA-I vari-
ants and ligands in circulation.
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